Skip to main content
. 2023 May 25;15(3):430–438. doi: 10.1016/j.chmed.2022.12.010

Fig. 2.

Fig. 2

Infarct regions and neurobehavioral disability restored by LTC treatment, revealed by TTC (2,3,5-triphenyltetrazoliumchloride) staining and neurological scores (mean ± SEM, n = 6). TTC staining of brain (A), infarct area (B), neurological deficit score measurement on 24 h after MCAO (C), neurological deficit score measurement on day 7 after MCAO (D). *P < 0.05, ***P < 0.001, relative to MCAO group.